High-dose intravenous methylprednisolone is effective in subacute thyroiditis unresponsive to oral steroids
European Thyroid Journal · 01.04.2026 · 15 (2)
DOI: 10.1530/etj-25-0346 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Thyroid Journal, online erschienen am 13.03.2026. Verfasst von Simone Rodolfi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy. Hauptthemen laut MEDLINE: Methylprednisolone, Thyroiditis, Subacute, Anti-Inflammatory Agents. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Subacute thyroiditis (SAT) relapsing or refractory to standard of care oral prednisone (OP) therapy is rare, but affected patients experience significant discomfort due to prolonged and uncontrolled neck pain. Here, we report the efficacy of high-dose intravenous methylprednisolone (IVMP) therapy in the treatment of such cases.
Methods
In this pilot study, we included 14 patients diagnosed with SAT in the period 2014–2024, in a single center. Therapy consisted of 500 mg of IVMP, divided into two weekly infusions and titrated down based on clinical response. Thyroid function tests, thyroid ultrasound, and inflammatory markers were assessed at baseline and throughout the follow-up up to 3–6 months after IVMP discontinuation.
Results
At baseline, 4 and 10 patients had thyrotoxicosis or were euthyroid, respectively. The median (IQR) duration of treatment was 26 days (21–38). At the end of the treatment, we observed a complete clinical, ultrasonographic, and biochemical response in twelve patients (86%), whereas thirteen (93%) had immediate resolution of neck pain and thyrotoxicosis. Only one patient did not improve at the end of IVMP protocol, and she was the only one experiencing a delayed remission with persistent hypothyroidism. Mild grade 1 and 2 adverse events (hyperglycemia, arterial hypertension, and neutrophilia) occurred in 8 out of 14 patients.
Conclusion
IVMP therapy resulted in a rapid clinical and ultrasonographic improvement in most patients with relapsing SAT unresponsive to oral steroids. This response allowed for a shorter treatment duration, with good tolerability, minimal adverse events, and a low incidence of hypothyroidism during follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
- Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy.
- Department of Endocrine and Metabolic Diseases, Endocrine Oncology Unit, IRCCS Istituto Auxologico Italiano, Milan, Italy.
- Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
- ASST Bergamo Est, Seriate, Italy.
- Endocrinology Unit ASST Santi Paolo e Carlo, Milan, Italy.
ORCID-Profile: Luca Persani, Laura Fugazzola, Irene Campi
Zitieren
APA
Rodolfi, S., Vannucchi, G. M., Perrino, M., Colombo, C., Covelli, D., Persani, L., Fugazzola, L., & Campi, I. (2026). High-dose intravenous methylprednisolone is effective in subacute thyroiditis unresponsive to oral steroids. European Thyroid Journal, 15(2). https://doi.org/10.1530/etj-25-0346
Vancouver
Rodolfi S, Vannucchi GM, Perrino M, Colombo C, Covelli D, Persani L, et al. High-dose intravenous methylprednisolone is effective in subacute thyroiditis unresponsive to oral steroids. European Thyroid Journal. 2026;15(2). doi:10.1530/etj-25-0346
BibTeX
@article{Rodolfi2026,
author = {Rodolfi, Simone and Vannucchi, Guia Maria and Perrino, Michela and Colombo, Carla and Covelli, Danila and Persani, Luca and Fugazzola, Laura and Campi, Irene},
title = {High-dose intravenous methylprednisolone is effective in subacute thyroiditis unresponsive to oral steroids},
journal = {European Thyroid Journal},
year = {2026},
volume = {15},
number = {2},
doi = {10.1530/etj-25-0346}
}
EUVIMED